Publication
Number of items: 7.
1 May 2021
  • New Psychoactive Substances (NPS) and Serotonin Syndrome onset: a Systematic Review. (2021) Fabrizio Schifano, Stephania Chiappini, John Corkery, Norbert Scherbaum, Flavia Napoletano, Davide Arillotta, Valeria Catalani, Alessandro Vento, Mauro Pettorruso, Giovanni Martinotti, Massimo di Giannantonio and Amira Guirguis
    • January 2010
  • Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosets. (2010) K. A. Stockwell, D. K. A. Scheller, L. A. Smith, S. Rose, Mahmoud M. Iravani, M. J. Jackson and P. Jenner
    • October 2009
  • Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction. (2009) K. A. Stockwell, D. Scheller, S. Rose, M. J. Jackson, K. Tayarani-Binazir, Mahmoud M. Iravani, L. A. Smith, C. W. Olanow and P. Jenner
    • August 2008
  • Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response. (2008) Mahmoud M. Iravani, Mona Sadeghian, Clement C. M. Leung, Banu C. Tel, Sarah Rose, Anthony H. Schapira and Peter Jenner
    • May 2008
  • Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets. (2008) K. A. Stockwell, D. J. Virley, M. Perren, Mahmoud M. Iravani, M. J. Jackson, S. Rose and P. Jenner
    • 2003
  • Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's Disease in marmoset monkeys. (2003) A. Eslamboli, H. F. Baker, R. M. Ridley and L.E. Annett
  • Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides anatomical and behavioural protection against 6-OHDA lesions in the common marmoset monkey (Callithrix jacchus). (2003) A. Eslamboli, R. M. Cummings, R. M. Ridley, H. F. Baker, N. Muzyczka, C. Burger, R. J. Mandel, D. Kirik and L.E. Annett